期刊文献+

黄芪注射液联合阿魏酸钠治疗原发性肾病综合征的效果观察 被引量:5

Effect observation of Huangqi injection combined with sodium ferulate in the treatment of primary nephrotic syndrome
下载PDF
导出
摘要 目的 研究黄芪注射液联合阿魏酸钠治疗原发性肾病综合征的效果,探讨其临床适用性。方法 选取2013年4月-2014年10月在本院就诊的78例原发性肾病综合征患者,将其随机分为对照组(39例)和实验组(39例)。对照组采用常规治疗及抗凝、改善脂代谢等对症治疗,实验组在对照组基础上给予黄芪注射液联合阿魏酸钠注射液静脉点滴,4周为1个疗程。比较两组治疗后的24 h尿蛋白、血清白蛋白、三酰甘油、总胆固醇及低密度脂蛋白含量。结果 治疗后,实验组的血清白蛋白含量明显上升,尿蛋白、三酰甘油、总胆固醇及低密度脂蛋白含量明显下降,对照组变化不明显,差异有统计学意义(P〈0.05),实验组的总有效率为97.44%,明显高于对照组的69.23%,差异有统计学意义(P〈0.05)。结论 黄芪注射液联合阿魏酸钠治疗原发性肾病综合征的效果显著,能明显改善患者的肾功能,值得临床推广应用。 Objective To study the effect of Huangqi injection combined with sodium ferulate in the treatment of primary nephrotic syndrome in order to explore its clinical applicability. Methods From April 2013 to October 2014,78 patients with primary nephrotic syndrome visited our hospital for treatment were selected and evenly divided into control group and experimental group in random.In control group,conventional treatment combined with symptomatic therapies like anticoagulation and improvement of lipid metabolism and so on was adopted.In experimental group,on the ba- sis of control group,Huangqi injection combined with sodium ferulate injection for intravenous drip was added.One course of treatment lasted 4 weeks.24 h urine protein,serum albumin,triglycerides,total cholesterol and low density lipoprotein level after treatment was compared respectively between two groups. Results After therapy,the content of serum albumin was greatly increased,while the content of urirre protein,triglycerides,total cholesterol and low density lipoprotein level was remarkably decreased in experimental group,while change in control group were not obvious,and there was a statistical difference (P〈0.05).The total effective rate in experimental group (97.44%) was obviously higher than that in control group (69.23%),and there was a statistical difference (P〈0.05). Conclusion Huangqi injection combined with sodium ferulate obtains a remarkable effect on treating primary nephrotic syndrome and can significantly improve renal function of patients.It is worthy of clinical promotion and application.
作者 陈春毅
出处 《中国当代医药》 2015年第20期109-111,共3页 China Modern Medicine
关键词 黄芪 阿魏酸钠 原发性肾病综合征 Huangqi Sodium ferulate Primary nephrotic syndrome
  • 相关文献

参考文献15

二级参考文献81

共引文献207

同被引文献50

  • 1王永钧,鲁盈.原发性肾病综合征的诊断、辨证分型及疗效评定(试行方案)[J].上海中医药杂志,2006,40(10):51-52. 被引量:158
  • 2Wang B H, Ou-Yang J P. Pharmacological actions of so- dium ferulate in cardiovascular system [ J ]. Cardiovasc Drug Rev, 2005,23 (2) : 161-172.
  • 3Goldmann B U, Rudolph V, Rudolph T K, et al. Neutro- phil activation precedes myocardial injury in patients with acute myocardial infarction [ J ]. Free Radic Biol Med, 2009,47( 1 ) :79-83.
  • 4Saeed S A, Waqar M A, Zubairi A J, et al. Myocardial ischaemia and reperfusion injury: reactive oxygen species and the role of neutrophil[ J]. J Coil Physicians Surg Pak, 2005,15 ( 8 ) :507-514.
  • 5A1-Amran F, Shahkolahi M. Oxytocin ameliorates the im- mediate myocardial injury in rat heart transplant through downregulation of neutrophil-dependent myocardial apop- tosis [ J ]. Transplant Proc, 2013,45 ( 6 ) : 2506-2512.
  • 6Pietruczuk M, Pietruczuk A, Pancewicz S, et al. ICAM- 1 : structure, biological role and clinical significance[ J ]. Pol Merkur Lekarski, 2004,17 ( I01 ) :507-511.
  • 7Kukielka GL, Youker KA, Hawkins HK, et al. Regula- tion of ICAM-1 and IL-6 in myocardial ischemia: effect of reperfusion [ J]. Ann N Y Acad Sci, 1994,723:258-270.
  • 8Long E O. ICAM-1 : getting a grip on leukocyte adhesion [J]. J Immunol, 2011,186(9) :5021-5023.
  • 9Benson V, McMahon A C, Lowe H C. ICAM-1 in acute myocardial infarction : a potential therapeutic target [ J ]. Curr Mol Med, 2007,7(2) :219-227.
  • 10Diaz-Meco M T, Moscat J. The atypical pkcs in inflam- mation: NF-kappa B and beyond [ J ]. Immunol Rev, 2012,246( 1 ) : 154-167.

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部